Amarin Corp Plcuk (AMRN) EBIT Margin Growth (5y) (2018 - 2026)

Amarin Corp Plcuk (AMRN) EBIT Margin Growth (5y) (2018 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,418.00
Dec 31, 2025 6,649.00
Sep 30, 2025 -1,792.00
Jun 30, 2025 -2,505.00
Mar 31, 2025 -2,437.00
Dec 31, 2024 1,520.00
Sep 30, 2024 -5,548.00
Jun 30, 2024 172.00
Mar 31, 2024 700.00
Dec 31, 2023 10,711.00
Sep 30, 2023 774.00
Jun 30, 2023 3,148.00
Mar 31, 2023 2,969.00
Dec 31, 2022 266.00
Sep 30, 2022 1,212.00
Jun 30, 2022 -4,133.00
Mar 31, 2022 2,366.00
Dec 31, 2021 -7,949.00
Sep 30, 2021 3,786.00
Jun 30, 2021 4,915.00